The Effects of Pre- and Post-transplant Anemia on 1-Year Survival After Cardiac Transplantation

Journal of Heart and Lung Transplantation

Volumn 27, Issue 4, 2008, Pages 394-399

  Taegtmeyer, Anne B ^a   Rogers, Paula ^a   Breen, Jane B ^a   Barton, Paul J ^a   Banner, Nicholas R ^a   Yacoub, Magdi H ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; ANEMIA; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HEART TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; SURVIVAL; UNSPECIFIED SIDE EFFECT;

ADULT; ANEMIA; COHORT STUDIES; FEMALE; HEART DISEASES; HEART TRANSPLANTATION; HEMOGLOBINS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 40949090526     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.01.014     Document Type: Article

References (24)

1. Anand I., McMurray J.J., Whitmore J., et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 110 (2004) 149-154
2. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 10 (2003) 223-225
3. Felker G.M., Gattis W.A., Leimberger J.D., et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 92 (2003) 625-628
4. Sharma R., Francis D.P., Pitt B., Poole-Wilson P.A., Coats A.J., and Anker S.D. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J 25 (2004) 1021-1028
5. Taegtmeyer A.B., and Banner N.R. Anaemia, polycythaemia and chronic heart failure. Curr Cardiol Rev 1 (2005) 117-126
6. Gleissner C.A., Murat A., Schafer S., et al. Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function. Transplantation 77 (2004) 710-717
7. Frost A.E., and Keller C.A. Anemia and erythropoietin levels in recipients of solid organ transplants. The Multi-Organ Transplant Group. Transplantation 56 (1999) 1008-1011
8. Müller H.M., Aigner R., Horina J.H., et al. Mild chronic anemia following heart transplantation: a syndrome with prognostic relevance?. Transpl Int 11 (1998) 413-418
9. Müller H.M., Horina J.H., Kniepeiss D., et al. Characteristics and clinical relevance of chronic anemia in adult heart transplant recipients. Clin Transplant 15 (2001) 343-348
10. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
11. Wexler D., Silverberg D., Sheps D., et al. Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure. Int J Cardiol 96 (2004) 79-87
12. Tanner H., Moschovitis G., Kuster G.M., et al. The prevalence of anemia in chronic heart failure. Int J Cardiol 86 (2002) 115-121
13. Szachniewicz J., Petruk-Kowalczyk J., Majda J., et al. Anemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 90 (2003) 303-308
14. Silverberg D.S., Wexler D., Blum M., et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35 (2000) 1737-1744
15. Bove A.A., Kashem A., Cross R.C., et al. Factors affecting Survival after heart transplantation: comparison of pre- and post-1999 listing protocols. J Heart Lung Transplant 24 (2006) 42-47
16. Krantz S.B. Pathogenesis and treatment of the anemia of chronic disease. Am J Med Sci 307 (1994) 353-359
17. Freudenberger R.S., and Carson J.L. Is there an optimal hemoglobin value in the cardiac intensive care unit?. Curr Opin Crit Care 9 (2003) 356-361
18. Silverberg D.S., Wexler D., Sheps D., et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 37 (2001) 1775-1780
19. Silverberg D.S., Wexler D., Blum M., et al. The effect of correction of anemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 18 (2003) 141-146
20. Mitka M. Researchers probe anemia-heart failure link. JAMA 290 (2003) 1835-1838
21. Felker G.M., Adams Jr. K.F., Gattis W.A., and O'Connor C.M. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44 (2004) 959-966
22. Mancini D.M., Katz S.D., Lang C.C., LaManca J., Hudaihed A., and Androne A.S. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107 (2003) 294-299
23. Besarab A., Bolton W.K., Browne J.K., et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339 (1998) 584-590
24. Campise M., Mikhail A., Quaschning T., Snyder J., and Collins A. Impact of pre-transplant anaemia correction and erythropoietin resistance on long-term graft survival. Nephrol Dial Transplant 20 suppl 8 (2005) viii8-viii12